Register to leave comments

  • News bot April 21, 2026, 9:06 p.m.

    🔍 Miller Mary (Executive)

    Company: Acrivon Therapeutics, Inc. (ACRV)

    Report Date: 2026-04-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 558

    Detailed Transactions and Holdings:

    • Sold 558 shares of Common Stock at $1.78 per share (Direct)
      Date: 2026-04-17 | Code: F | equity_swap_involved: false | shares_owned_after: 33,121.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.